Year,ICD10 Diagnosis_x,Diagnosis Type_x,Metric_x,Sex_x,Value_x,ICD10 Diagnosis_y,Diagnosis Type_y,Metric_y,Sex_y,Value_y,"Tobacco Price
Index","Retail Prices
Index",Tobacco Price Index Relative to Retail Price Index,Real Households' Disposable Income,Affordability of Tobacco Index,Household Expenditure on Tobacco,Household Expenditure Total,Expenditure on Tobacco as a Percentage of Expenditure,All Pharmacotherapy Prescriptions,Nicotine Replacement Therapy (NRT) Prescriptions,Bupropion (Zyban) Prescriptions,Varenicline (Champix) Prescriptions,Net Ingredient Cost of All Pharmacotherapies,Net Ingredient Cost of Nicotine Replacement Therapies (NRT),Net Ingredient Cost of Bupropion (Zyban),Net Ingredient Cost of Varenicline (Champix),Method,Sex,16 and Over,16-24,25-34,35-49,50-59,60 and Over,year_numeric,Predicted_Mortality_Risk
2014.5,All admissions,All admissions,Number of admissions,,11011882,,,,,,815.9,321.3,255.2,192.3,76.7,16209.0,928265.0,1.8,1348.0,766.0,21.0,561.0,38145.0,18208.0,807.0,19129.0,,,21.0,25.0,26.0,24.0,21.0,13.0,0,1
